More results...

More results...

ESMO Asia 2024

We are thrilled to announce our participation in the ESMO Asia Congress 2024!

Join the SOPHiA GENETICS team at booth #E406 and explore how we are driving groundbreaking innovations in cancer research and treatment.

From our collaboration with Memorial Sloan Kettering cancer Center to decentralize MSK-ACCESS and MSK-IMPACT, to our launch of SOPHiA DDM™ Residual Acute Myeloid (RAM) Solution, we are committed to supporting clinical researchers with variant detection and analysis, biomarker discovery, and therapy selection.

We look forward to connecting with you at ESMO Asia 2024!

Event Date
December 6, 2024 – December 8, 2024

Event Type

In-person

Event Location

Asia

Areas of Interest

Solid Tumor, Liquid Biopsy, Genomics, Blood Cancer

Book a Meeting

Disclaimer notice:

The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.

The opinions expresseda during this presentation are these of the speaker and may not represent the opinions of SOPHiA GENETICS.

SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.
';